Publications

Press, et al. "Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials.", Clinical Cancer Research 2005; 11(18) September 15, 2005.

Mass, R.D. et al, "Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with Trastuzumab.", Clinical Breast Cancer, 2005, 6, (3), 240-6.

Dybdal, N. et al. "Determination of HER2 gene amplification by fluorescence in situ hybridization and concordance with the clinical trials immunohistochemical assay in women with metastatic breast cancer evaluated for treatment with Trastuzumab.", Breast Cancer Research and Treatment 2005, 93, (1), 3-11.

Pauletti G, Godolphin W, Press M, Slamon DJ: "Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization." Oncogene 1996; 13:63-72. 

Pauletti G, Dandekar S, Rong HM, et al: "Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry." J Clin Oncol 2000; 18, 21: 3651-3664.